Cipro and Vaginal infection - a phase IV clinical study of FDA data

Summary:

Vaginal infection is found among people who take Cipro, especially for people who are 40-49 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Cipro and have Vaginal infection. It is created by eHealthMe based on reports of 27,732 people who have side effects when taking Cipro from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 23, 2022

27,732 people reported to have side effects when taking Cipro.
Among them, 59 people (0.21%) have Vaginal infection.


What is Cipro?

Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 29,951 Cipro users for its effectiveness, alternative drugs and more.

What is Vaginal infection?

Vaginal infection is found to be associated with 1,414 drugs and 759 conditions by eHealthMe.

Number of Cipro and Vaginal infection reports submitted per year:

Could Cipro cause Vaginal infection?

Time on Cipro when people have Vaginal infection *:

  • < 1 month: 50 %
  • 1 - 6 months: 50 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Age of people who have Vaginal infection when taking Cipro *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 12.73 %
  • 20-29: 5.45 %
  • 30-39: 1.82 %
  • 40-49: 40.0 %
  • 50-59: 12.73 %
  • 60+: 27.27 %

Common drugs people take besides Cipro *:

  1. Aredia: 27 people, 45.76%
  2. Zometa: 27 people, 45.76%
  3. Levaquin: 25 people, 42.37%
  4. Paxil: 24 people, 40.68%
  5. Decadron: 24 people, 40.68%
  6. Percocet: 24 people, 40.68%
  7. Neurontin: 23 people, 38.98%
  8. Flexeril: 23 people, 38.98%
  9. Vicodin: 23 people, 38.98%
  10. Abraxane: 22 people, 37.29%

Common side effects people have besides Vaginal infection *:

  1. Stress And Anxiety: 37 people, 62.71%
  2. Rashes (redness): 37 people, 62.71%
  3. Haemorrhoids (a swollen vein or group of veins in the region of the anus): 34 people, 57.63%
  4. Urinary Retention (the inability to completely or partially empty the bladder): 32 people, 54.24%
  5. Back Pain: 32 people, 54.24%
  6. Pain: 31 people, 52.54%
  7. Joint Pain: 30 people, 50.85%
  8. Weakness: 28 people, 47.46%
  9. Urination - Painful: 28 people, 47.46%
  10. Bone Pain: 26 people, 44.07%

Common conditions people have *:

  1. Stress And Anxiety: 22 people, 37.29%
  2. Metastases To Bone (cancer spreads to bone): 7 people, 11.86%
  3. Urinary Retention (the inability to completely or partially empty the bladder): 5 people, 8.47%
  4. Sinus Disorder (disease of sinus): 5 people, 8.47%
  5. Anaemia (lack of blood): 5 people, 8.47%
  6. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 5 people, 8.47%
  7. Depression: 4 people, 6.78%
  8. Autoimmune Hepatitis: 4 people, 6.78%
  9. Breast Cancer Metastatic: 3 people, 5.08%
  10. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 5.08%

* Approximation only. Some reports may have incomplete information.

Do you take Cipro and have Vaginal infection?

Check whether Vaginal infection is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Cipro:

Vaginal infection treatments and more:

COVID vaccines that are related to Vaginal infection:

How severe was Vaginal infection and when was it recovered:

Expand to all the drugs that have ingredients of ciprofloxacin hydrochloride:

Common drugs associated with Vaginal infection:

All the drugs that are associated with Vaginal infection:

Common conditions associated with Vaginal infection:

All the conditions that are associated with Vaginal infection:

How the study uses the data?

The study uses data from the FDA. It is based on ciprofloxacin hydrochloride (the active ingredients of Cipro) and Cipro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: